These results identified PI3K/AKT/Snail signaling as a pivotal regulator of EMT and MDR process in sorafenib-resistant HCC cells, and this mechanism may serve as a potential therapeutic target. The gene discussed is SNAI1; the disease is hepatocellular carcinoma.